Metallic taste in cancer patients treated with chemotherapy

Highlights • Metallic taste is reported by 9.7% to 78% of chemotherapy treated cancer patients. • Research regarding metallic taste is limited. • Consequences of metallic taste regarding food intake, body weight, and quality of life are unknown. • Several management strategies can be recommended to...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer treatment reviews 2015-02, Vol.41 (2), p.179-186
Hauptverfasser:	IJpma, I, Renken, R.J, ter Horst, G.J, Reyners, A.K.L
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - adverse effects Cancer patients Chemotherapy Cyclophosphamide - adverse effects Doxorubicin - adverse effects Fluorouracil - adverse effects Hematology, Oncology and Palliative Medicine Humans Interviews as Topic Metallic taste Neoplasms - drug therapy Platinum Compounds - adverse effects Prevalence Quality of Life Surveys and Questionnaires Taste Disorders - chemically induced Taste Disorders - epidemiology Taste Disorders - physiopathology Taste Disorders - prevention & control Time Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Highlights • Metallic taste is reported by 9.7% to 78% of chemotherapy treated cancer patients. • Research regarding metallic taste is limited. • Consequences of metallic taste regarding food intake, body weight, and quality of life are unknown. • Several management strategies can be recommended to support cancer patients.
ISSN:	0305-7372 1532-1967
DOI:	10.1016/j.ctrv.2014.11.006